Cassava Sciences Inc (NASDAQ:SAVA) does about 2.46M shares in volume on a normal day but saw 13941661 shares change hands in the recent trading day. The company now has a market cap of 1.68B USD. Its current market price is $35.08, marking an increase of 20.51% compared to the previous close of $29.11. The 52 week high reached by this stock is $32.10 whilst the lowest price level in 52 weeks is $8.79.
Cassava Sciences Inc (SAVA) has a 20-day trading average at $15.53 and the current price is 9.28% off the 52-week high compared with 299.09% distance from its 52-week low. The 50-day simple moving average of the closing price is $17.29 and its 200-day simple moving average is $21.11. If we look at the stock’s price movements over the week, volatility stands at 33.45%, which decreases to 19.03% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 83.16 to suggest the stock is overbought.
The consensus objective for the share price is $91.00, suggesting that the stock has a potential upside of 61.45% over the period.
0 analysts have rated it as a buy and 2 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Moderate Buy the stock.
B. Riley Securities also downgraded the stock to “Neutral” from Buy on November 16, 2022 at a price target of $44. Cantor Fitzgerald downgraded its price target at $100.
Cassava Sciences Inc (SAVA) stock is up 94.67% over the week and 243.42% over the past month. Its price is 55.84% year-to-date and 68.33% over the past year.
The stock last released its quarterly earnings report for quarter ended 3/31/2024, with the company’s earnings per share (EPS) of -0.63 below consensus estimates by -0.04. The company’s next earnings report forecasts estimating quarterly EPS at -0.4 and -0.78 for whole year.
To reach the target analysts have set, the stock logically needs to grow 61.45 percent from here.
The company has a return on investment of -60.95% and return on equity of -33.90%. The forward price to earnings ratio is 97.44. The beta has a value of -0.66. Price to book ratio is 19.30.
